fosphenytoin

(redirected from Fosphenytoin sodium)
Also found in: Medical.

fos·phen·y·to·in

 (fŏs′fĕn′ĭ-tō′ĭn, -fə-nĭt′ō-)
n.
A prodrug that is metabolized to phenytoin and administered parenterally for the treatment of seizures.

[Alteration of phos(phorus) + phenytoin.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
Also debuting in late December was a generic option to Pfizer Inc.'s Cerebyx injection (fosphenytoin sodium injection USP), used for treatment of certain types of severe seizures.
Pharmaceutical company Mylan NV (TASE:MYL) stated on Thursday that it has introduced Fosphenytoin Sodium Injection USP, 75 mg/ml, (50 mg PE/ml) in the US market
Ltd announced today that they will launch the anticonvulsant agent Fostoin 750 mg for Injection (fosphenytoin sodium hydrate, "fostoin") on January 17.
Because fosphenytoin sodium 1.5 mg is equivalent to phenytoin sodium 1.0 mg, a 100 mg dose of IM phenytoin is ordered as "fosphenytoin 100 mg PE" rather than the conventional "fosphenytoin 150 mg" (Pfizer, 2002).
Fosphenytoin sodium was approved for intravenous (IV) or intramuscular (IM) administration in the treatment of SE, as well as for the prevention or treatment of seizures in patients who cannot take oral AEDs.
Fosphenytoin sodium (Cerebyx[R]) - Parke-Davis) is a new drug developed specifically to replace intravenous phenytoin sodium (Dilantin[R] - Parke-Davis).
NEW YORK -- Amneal Biosciences, a unit of Amneal Pharmaceuticals LLC, has launched its first product: generic fosphenytoin sodium injection.
16 January 2012 - Nobelpharma Co Ltd and Eisai Co Ltd (TYO:4523) announced on Monday plans to launch the anticonvulsant agent Fostoin 750 mg for Injection (fosphenytoin sodium hydrate, fostoin) on 17 January 2012 in Japan.